Amgen Inc.

Pharmaceuticals
United States
Earnings Per Share Growth (%)35.22%
Cost of Goods Sold (US$ Millions)$4,227
Current Liabilities (US$ Millions)$8,667
Total Assets (US$ Millions)$38,518
Long Term Debt$29,306
Return on Equity26.92%
Revenue (US$ Millions)$21,662
Total Company Assets$71,576
Revenue Growth (%)7.97%
Net Income (US$ Millions)$6,939
Earnings Per Share (US$)$35.22
Total Equity (US$ Millions)$28,083
Profit Margin (%)32.03%
Debt To Equity Ratio (%)1.04%
Inventory Turnover$2,435